ArticlePloS one2026
A modular deep learning architecture for interpretable disease prediction across tabular clinical and biometric datasets.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate disease prediction using clinical datasets is essential for improving early diagnosis and clinical decision-support systems; however, many existing deep learning approaches are disease-specific, computationally intensive, and difficult to generalize across heterogeneous biomedical datasets. This study addresses this challenge by proposing a unified and dataset-aware deep learning framework that enables accurate and interpretable disease prediction across diverse clinical datasets. The framework adopts a modular architecture that selects appropriate models based on dataset characteristics such as feature dimensionality, sample size, and class imbalance. It integrates multiple deep learning architectures, including MLP, one-dimensional CNN, FT-Transformer, autoencoder-based classifiers, and ensemble strategies. Robust preprocessing, fold-safe feature selection, and nested cross-validation are incorporated to ensure reliable performance evaluation. The framework is evaluated on three heterogeneous benchmark datasets: the UCI Heart Disease dataset (303 samples, 13 clinical features), the PIMA Indians Diabetes dataset (768 samples, 8 metabolic features), and the Parkinson's disease voice dataset (195 recordings, 22 acoustic features). Experimental results demonstrate competitive predictive performance relative to classical baselines across the diverse tasks. The FT-Transformer + autoencoder ensemble achieved an AUC of 0.8980 (±0.0483) for heart disease prediction, while the CNN + Autoencoder ensemble obtained an AUC of 0.8451 (±0.0270) for diabetes classification. For Parkinson's disease detection, the MLP achieved an AUC of 0.7538 with perfect specificity. Overall, all models achieved AUC values comparable to ML baselines. The study contributes a scalable and interpretable deep learning framework that improves reliability, generalization, and practical applicability for multi-disease prediction in real-world healthcare environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.